NATRConsumer Defensive · Packaged FoodsThe 2 Wall Street analysts covering Nature's Sunshine Products, Inc. hold a median 12-month price target of $25 — +94.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 81 of 100 as at 4 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Nature's Sunshine Products, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (100): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Revisions (27): Analysts have, on balance, been cutting their forecasts.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on NATR, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +94.7% from it.
Of the 20 most recent actions, 0 moved their price target up and 3 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 31 Oct 2026 | Canaccord Genuity | Maintains | Buy | — |
| 30 Oct 2026 | Canaccord Genuity | Maintains | Buy | $36 → $25 |
| 10 Aug 2026 | DA Davidson | Maintains | Buy | — |
| 10 Aug 2026 | DA Davidson | Maintains | Buy | $33 → $25 |
| 30 July 2026 | Canaccord Genuity | Maintains | Buy | — |
| 30 July 2026 | Canaccord Genuity | Maintains | Buy | $37 → $36 |
| 11 May 2026 | DA Davidson | Maintains | Buy | $33 |
| 11 May 2026 | DA Davidson | Maintains | Buy | — |
| 12 Mar 2026 | DA Davidson | Maintains | Buy | — |
| 11 Mar 2026 | Canaccord Genuity | Maintains | Buy | — |
| 10 Mar 2026 | Canaccord Genuity | Maintains | Buy | — |
| 10 Nov 2025 | DA Davidson | Maintains | Buy | — |
| 1 Aug 2025 | Canaccord Genuity | Maintains | Buy | — |
| 3 June 2025 | DA Davidson | Maintains | Buy | — |
| 13 Sept 2024 | Canaccord Genuity | Initiates | Buy | — |
| 12 Aug 2024 | DA Davidson | Maintains | Buy | — |
| 13 Mar 2024 | DA Davidson | Maintains | Buy | — |
| 9 Nov 2023 | DA Davidson | Maintains | Buy | — |
| 11 Aug 2023 | DA Davidson | Maintains | Buy | — |
| 10 May 2023 | DA Davidson | Reiterates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
NATR appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, Nature's Sunshine Products, Inc. returned −6.6% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 51% of US stocks
Cheaper than 83% of US stocks
Cheaper than 59% of US stocks
Cheaper than 55% of US stocks
Higher than 32% of US stocks
Higher than 15% of US stocks
Higher than 86% of US stocks
Higher than 54% of US stocks
Higher than 57% of US stocks
Higher than 66% of US stocks
Higher than 85% of US stocks
Higher than 97% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Nature's Sunshine Products, Inc. has a market value of $226.1M and an enterprise value of $151.3M.
Revenue in the twelve months to 30 June 2026: $492.0M. The latest quarter grew 1.9% year on year.
Net income over the same four quarters: $18.7M, a 3.8% net margin.
Diluted earnings per share, trailing twelve months: $1.01.
Free cash flow in the twelve months to 30 June 2026: $18.1M.
Nature's Sunshine Products, Inc. spent $6.5M on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: 12.7×; forward P/E: 11.0× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 15.56%, paying out 0% of earnings.
Nature's Sunshine Products, Inc. employs 806 people — $610K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Nature's Sunshine Products, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Nature's Sunshine Products lowered its full-year 2026 sales and earnings outlook after third-quarter revenue fell 9%. The company cited weakness in China and Taiwan and a slowdown in its North American digital business.
Why it matters — The lower outlook and revenue decline indicate that regional weakness and slower digital business are affecting NATR's results.
Nature's Sunshine Products reported financial results for the third quarter ended September 30, 2026. The excerpt provides no specific financial figures or year-over-year comparisons.
Why it matters — The quarterly results announcement is relevant to NATR watchers, but the supplied excerpt does not include details to assess the results.
Nature’s Sunshine will hold a conference call on November 4, 2026, at 5:00 p.m. ET to discuss third-quarter results for the period ended September 30. The company said it will issue its results in a press release before the call.
Why it matters — NATR watchers can note the scheduled timing for the company’s third-quarter results release and discussion.
Seeking Alpha has rated Nature's Sunshine Products as a Buy with a $18 price target, citing a debt-free balance sheet, cash reserves equal to one-third of market cap, and the highest gross margin in four years at 73.6%. The report highlights that digital subscriptions, now 10% of sales, generate three times higher customer lifetime value and recurring cash flows, offsetting weaker traditional channels.
Why it matters — A NATR watcher would care because the item highlights the company's financial strength (zero debt, strong cash position) and the growing contribution of its higher-value digital subscription business.
Nature's Sunshine Products was upgraded to "strong buy" despite a 47.9% stock decline and reduced 2026 guidance. The company is described as fundamentally healthy, with $82.5M in cash reserves, zero debt, low valuation multiples versus peers, modest revenue growth, and stable cash flows.
Why it matters — For NATR watchers, the upgrade highlights the company's resilient balance sheet and strategic flexibility despite recent stock declines and lowered guidance.
The 2 Wall Street analysts covering Nature's Sunshine Products, Inc. have a median 12-month price target of $25, with estimates ranging from $25 to $25. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 2 analysts covering Nature's Sunshine Products, Inc., 2 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Nature's Sunshine Products, Inc. 81 out of 100 across roughly 4,600 US stocks as at 4 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 4 Nov 2026, Nature's Sunshine Products, Inc. ranks 81 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (100 of 100).
No one can know that. What the data says: the median 12-month target from 2 analysts implies +94.7% from the last close, and Ticker Nerd's factor model ranks Nature's Sunshine Products, Inc. 81 out of 100 as at 4 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Nature's Sunshine Products, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NATR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $25 to $25 over the next 12 months.
Nature's Sunshine Products, Inc. returned -6.6% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
Nature's Sunshine Products, Inc. is a natural health and wellness company that manufactures and markets nutritional supplements and personal care products.
The most recent item we track (MarketBeat, 5 Nov 2026): "What Nature's Sunshine Products (NATR) Said on Its Q3 Earnings Call". Nature's Sunshine Products lowered its full-year 2026 sales and earnings outlook after third-quarter revenue fell 9%. The company cited weakness in China and Taiwan and a slowdown in its North American digital business.
Nature's Sunshine Products, Inc. is a natural health and wellness company that manufactures and markets nutritional supplements and personal care products. Nature's Sunshine Products offers a broad range of products focused on general health, immune support, cardiovascular wellness, digestive health, weight management, and personal care. The company distributes its products through a direct-selling model supported by independent managers, distributors, and customers, and it serves markets across North America, Latin America, Europe, Asia, and other international regions. Nature's Sunshine Products also operates through multiple product brands and geographic business segments, reflecting its presence in both consumer wellness and specialty nutrition categories. Its role in the market is centered on providing branded wellness products that combine manufacturing, distribution, and direct customer engagement across a global footprint.
CEO Mr. Kenneth G. Romanzi · 806 employees · United States · https://www.naturessunshine.com
